Combination Therapy With Radium-223 and Enzalutamide in Castration-Resistant Prostate Cancer

被引：0
|
作者：
Maughan, Benjamin L. [1 ]
机构：
[1] Huntsman Canc Inst, Salt Lake City, UT 84112 USA
来源：
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY | 2021年 / 19卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：764 / 766
页数：3
相关论文
共 50 条
  • [31] Managing Radium-223 Therapy in patients with Metastatic Castration-Resistant Prostate Cancer - Developing a multiprofessional team
    Cruz, M. Botelho
    Aniceto, D.
    Nunes, A.
    Mills, C.
    Lewington, V.
    Fahim, H.
    Allen, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S665 - S665
  • [32] Impact of treatment delay in Radium-223 Dichloride therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, M. O.
    Holm, S.
    Petersen, P. M.
    Daugaard, G.
    Mortensen, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S214 - S214
  • [33] Prediction of hematological toxicity in Radium-223 therapy in patients with advanced metastatic castration-resistant prostate cancer
    Fosbol, M. O.
    Petersen, P. M.
    Kjaer, A.
    Mortensen, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S330 - S330
  • [34] Prognostic biomarkers in the use of radium-223 in patients with metastatic castration-resistant prostate cancer
    Vidal, M.
    Cardenas-Perilla, R.
    Delgado, A.
    Moron, S.
    Blair, J. L. Londono
    Vega, I.
    Ochoa, J. J. Correa
    Rojas, J.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2023, 42 (05): : 310 - 317
  • [35] Radium-223 for the treatment of bone metastases in castration-resistant prostate cancer: when and why
    Gallicchio, Rosj
    Mastrangelo, Pietro A.
    Nardelli, Anna
    Mainenti, Pier Paolo
    Colasurdo, Antonio P.
    Landriscina, Matteo
    Guglielmi, Giuseppe
    Storto, Giovanni
    [J]. TUMORI JOURNAL, 2019, 105 (05): : 367 - 377
  • [36] Radium-223 Is the Preferred Therapy in Bone-Predominant Symptomatic Metastatic Castration-Resistant Prostate Cancer
    Dreicer, Robert
    Li, Jing
    Andrew, J.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (05) : 293 - +
  • [37] Radium-223 Dichloride for Metastatic Castration-resistant Prostate Cancer: The Urologist's Perspective
    Shore, Neal D.
    [J]. UROLOGY, 2015, 85 (04) : 717 - 724
  • [38] Circulating Tumor Cells and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Pleskow, H.
    Otani, K.
    Kusaka, E.
    Ukleja, J.
    Balza, R.
    Fisher, R.
    Broderick, K.
    Maheswaran, S.
    Haber, D.
    Saylor, P. J.
    Miyamoto, D. T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E534 - E535
  • [39] Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
    Vidal, Monica
    Delgado, Alejandro
    Martinez, Carlos
    Jaime Correa, Jose
    Cristina Durango, Isabel
    [J]. INTERNATIONAL BRAZ J UROL, 2020, 46 (04): : 599 - 611
  • [40] Circulating and Imaging Biomarkers of Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Saylor, Philip J.
    Otani, Keisuke
    Balza, Rene
    Ukleja, Jacob
    Pleskow, Haley
    Fisher, Rebecca
    Kusaka, Erika
    Otani, Yukako S.
    Badusi, Priscilla Oluwakemi
    Smith, Matthew R.
    Meneely, Erika
    Olivier, Kara
    Lowe, Alarice C.
    Toner, Mehmet
    Maheswaran, Shyamala
    Haber, Daniel A.
    Yeap, Beow Y.
    Lee, Richard J.
    Miyamoto, David T.
    [J]. JCO PRECISION ONCOLOGY, 2024, 8
12345